Comparative Study on Different Bone Reconstruction After Chest Wall Tumor Resection
Comparative Study on the Effect of New Reconstruction Methods and Traditional Reconstruction Methods on Bone Reconstruction After Chest Wall Tumor Resection
1 other identifier
interventional
50
0 countries
N/A
Brief Summary
Chest wall tumors are one of the important diseases in thoracic surgery, and surgery is still the main treatment for this disease in clinical practice. Surgery for chest wall tumors requires extensive resection. However, the extensive chest wall defect formed after extensive resection can lead to the destruction of the integrity and stability of the chest wall, thus requiring chest wall reconstruction. The reconstruction of the chest wall after resection has always been a difficult point in chest wall tumor surgery, and the reconstruction of the chest wall bone is a key point in chest wall reconstruction. The goals of successful chest wall bone reconstruction include restoring chest wall rigidity, minimizing chest wall deformities, maintaining lung mechanics, and protecting thoracic organs. At present, traditional reconstruction methods are based on simulating and restoring the anatomical structure of the thoracic spine. For certain special areas of chest wall defects (such as posterior rib and paraspinal tumors), it is difficult to perform residual fixation; At the same time, traditional reconstruction methods suffer from insufficient stability after reconstruction, such as loosening, detachment, displacement, and even fracture. Therefore, it is necessary to design new chest wall reconstruction methods to meet clinical needs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2025
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 11, 2025
CompletedFirst Posted
Study publicly available on registry
May 29, 2025
CompletedStudy Start
First participant enrolled
July 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
ExpectedMay 29, 2025
May 1, 2025
1 month
May 11, 2025
May 20, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Stability of implants
The occurrence of detachment, displacement, and fracture of implants during follow-up in patients undergoing chest wall tumor surgery after receiving a new reconstruction method
3 years
Secondary Outcomes (10)
Respiratory discomfort
3 years
Postoperative complications
3 years
Complications of implants
3 years
Postoperative physical function status
3 years
Quality of life
3 years
- +5 more secondary outcomes
Study Arms (2)
new methods on bone reconstruction after chest wall tumor resection
EXPERIMENTALUsing noose fixation for thoracic bone reconstruction
traditional methods on bone reconstruction after chest wall tumor resection
ACTIVE COMPARATORUsing bridging method for thoracic bone reconstruction
Interventions
Selecting appropriate implants for chest wall bone reconstruction
Eligibility Criteria
You may qualify if:
- years old, male or female not limited
- Anesthesia ASA score I-II
- Malignant tumor of soft tissue in the chest
- Malignant tumors of ribs, rib cartilage, and sternum
- Tumors with uncertain or unknown properties of ribs, rib cartilage, and sternum
- Giant benign tumors of ribs, rib cartilage, and sternum
- The preoperative examination results indicate that the tumor has not undergone distant metastasis
- Willing to participate in the research and sign the informed consent form
You may not qualify if:
- Patients with distant metastasis detected during preoperative examination
- Inoperable tumor
- During the examination, it was discovered that the patient had another type of malignant tumor present
- ECOG 4
- Suffering from active or chronic fungal/bacterial/viral infections
- History of allergy to anesthesia related drugs
- Heart and lung dysfunction, liver and kidney dysfunction, inability to tolerate surgery
- Patients with mental disorders who are unable to cooperate with treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SEQUENTIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Thoracic Surgery
Study Record Dates
First Submitted
May 11, 2025
First Posted
May 29, 2025
Study Start
July 1, 2025
Primary Completion
July 31, 2025
Study Completion (Estimated)
December 31, 2028
Last Updated
May 29, 2025
Record last verified: 2025-05
Data Sharing
- IPD Sharing
- Will not share